EpigenCare
| EpigenCare | |
|---|---|
 EpigenCare ICO Review | |
| EpigenCare ICO | |
| Ticker: | EPIC |
| ICO start: | 2018-04-16 00:00:00 |
| ICO end: | 2018-07-31 00:00:00 |
| Price: | 1 EPIC = 0.40 USD |
| Bonus: | 1 |
| Tokens: | 50 EPIC |
| Tokentype: | ERC20 |
| Hardcap: | 20 000 000 USD |
| Platform: | Ethereum |
| Distributed: | 50% |
| Minimum: | 400 USD |
| Accepting: | ETH |
EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers will be able to receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin’s epigenetic profiles. A reward mechanism is implemented to encourage recurring tests and create transaction records on the blockchain ledger. This tokenization of data allows consumers to verify that their data is used solely for their own benefit in the structured ecosystem, solving the problem of perceived instrusiveness associated with personal tests requiring consumer DNA.
Contents
Description
Scientifically Grounded
How does a consumer know whether a skincare product is truly working for them? EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers will be able to receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin’s epigenetic profiles. The recommendation engine looks at the functional state of a panel of epigenetic markers strongly correlated with skin quality indicators (e.g., aging, moisture retention, elasticity, etc.), and how skincare product ingredients affect them.
A Cyclical Growth Ecosystem
As epigenetics regulates gene function and dynamically changes based on environment stimuli such as skincare product ingredients, it is a perfect fit for a recurring, tokenized business model. EpigenCare’s upcoming platform will be a structured ecosystem that allows skincare companies to target data segments with products that fulfill the recommendation engine’s matching requirements. Consumers that fall within the segment are rewarded with tokens, which can be used to subsidize additional tests (thereby generating additional advertising inventory for companies).
Disrupting the Skincare Industry
Their structured ecosystem allows for true leveraging of blockchain technology. The recurring nature of epigenetics allows for a perpetual incentivization model through data tokenization. By associating a transaction hash ID with each purchased test and data segment, we will be able to transparently prove that a consumer’s data is used only for their own benefit, thereby addressing the problem of perceived intrusiveness often associated with commercialized DNA-related testing. EpigenCare’s disruptive innovation introduces a new marketing channel to the $130 billion skincare industry and transform the way companies market their products to consumers through scientifically screened, individualized advertising.
Roadmap
| “ | Q2, 2017: EpigenCare Inc. Established in New York, USA Q4 2017 : Epigenetic-based Skincare Test Successfully Developed and Proven Q1 2018 : ICO Token Generation Event Q2 2018 : Launch Marketing Campaign for Product Pre-Orders Q3 2018 : Limited Launch of Beta Skincare Test Q4 2018 : Full Skincare Test Launch to Public; Launch EpigenCare Network Open Beta Q1 2019 : Launch Consumer Mobile Application Q2 2019 : Launch Official EpigenCare Network Platform Q3 2019 : Retail Distribution Initiative; Deploy API (Application Programming Interface) Q4 2019 : Dermatologist/Spa/Beauty Salon Partnership Initiative Future Objectives: Integrate Deep-Learning Artificial Intelligence Elements Based on Epigenetic Skin Data; Develop Complementary A-I-Based Mobile Imaging Application[1] | ” |
Team
| name: | title: | links: | group: | photo: | iss: |
|---|---|---|---|---|---|
| Richard Wildnauer, Ph.D. | Business Advisor | https://www.linkedin.com/in/richard-wildnauer/ | Advisors |  | 3.3 |
| James Wang, MD | Dermatology Advisor | https://www.linkedin.com/in/drjamesywang/ | Advisors |  | 3.3 |
| Brennan Bennett | Blockchain Advisor | https://www.linkedin.com/in/brennanbennett/;https://twitter.com/BockchainHIT | Advisors |  | 13.5 |
| Rebecca Fry, Ph.D. | Epigenetics Advisor | https://www.linkedin.com/in/rebecca-fry-1ab2694/ | Advisors |  | 3.3 |
| Tim Bukher | Legal Strategy Advisor | https://www.linkedin.com/in/timbukher/;https://www.bukher.io/ | Advisors |  | 6.2 |
| William Lee | Chief Executive Officer | https://www.linkedin.com/in/williamll/ | Team |  | 3.3 |
| Adam Weiwei Li, Md, Ph.d. | Chief Scientific Officer | https://www.linkedin.com/in/adam-weiwei-li-md-ph-d-2b0653157/ | Team |  | 3.3 |
| Jessica Li | Chief Financial Officer | https://www.linkedin.com/in/jessica-li-mba-816002158 | Team |  | 3.3 |
| Ashley Pottash | Business Strategy Lead | https://www.linkedin.com/in/ashley-pottash-2a9594a/ | Team |  | 3.3 |
| Stephen Fiser | Software Development Lead | https://www.linkedin.com/in/stephenfiser/ | Team |  | 3.3 |
External links
EpigenCare on Twitter
EpigenCare on Telegram
EpigenCare on Facebook
EpigenCare on Medium
EpigenCare on Bitcointalk
EpigenCare on Github
EpigenCare on Reddit
EpigenCare on Youtube
EpigenCare Official Website
EpigenCare Bounty
EpigenCare Whitepaper
Twitter
Telegram
